Vanguard Group Inc Lucid Diagnostics Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 888,874 shares of LUCD stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
888,874
Previous 560,915
58.47%
Holding current value
$1.14 Million
Previous $443,000
198.87%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding LUCD
# of Institutions
49Shares Held
9.45MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA2.73MShares$3.49 Million0.21% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL1.89MShares$2.42 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny459KShares$587,6030.0% of portfolio
-
Luminus Management LLC Houston, TX457KShares$584,5040.62% of portfolio
-
Ghisallo Capital Management LLC Greenwich, CT422KShares$540,1650.24% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $49.4M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...